The Signal Expert insights and opinions on clinical research and drug development. Expert insights and opinions on clinical research and drug development. Author: Signant Health CTAD 2021: Scientific Posters Compilation November 17, 2021 Signant Health Posted in Scientific Advisory At the 14th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, hosted in Boston from November 9-12, 2021, Signant’s renowned… Read More Benefits of Integrating SmartSignals RTSM with Supplies Solutions November 2, 2021 Signant Health Posted in Clinical Supplies Have you been considering your upcoming study’s supply chain strategy? You’ll want digital tools that are designed for your specific trial. Look no… Read More 5 Reasons to Prioritize Rater Training October 29, 2021 Signant Health Posted in Scientific Advisory The quality of assessments is an essential clinical trial component that is often overlooked. In placebo-controlled trials, accurate ratings are… Read More Get to Know the SME: Todd Feaster, PsyD. October 11, 2021 Signant Health Posted in Scientific Advisory In the first of this new series of Q&A interviews with Signant’s subject matter experts, we sat down with Todd… Read More 2021 SCRS Global Site Solutions Summit Recap October 5, 2021 Signant Health Posted in Events This past week, Signant Health’s Chief Marketing Officer, Scott Connor, and Chief Operating Officer, Jason Martin, participated as panelists at… Read More ISCTM Autumn Conference 2021: Poster Presentations Roundup October 5, 2021 Signant Health Posted in Events The International Society for CNS Clinical Trials and Methods (ISCTM) hosted its 2021 Autumn Conference from Sept 30 – October… Read More eCOA Best Practices: Ensuring Timely Delivery of Translations October 4, 2021 Signant Health Posted in eCOA With more than half of all registered studies occurring in locations outside of the U.S. and the continued upward trajectory… Read More eConsent Task Force Co-Chaired by Signant and Medidata Honored as Finalists for TOPRA Innovation Award September 16, 2021 Signant Health Posted in eConsent In 2019, a team of industry experts formed a task force to examine challenges and opportunities in the adoption of… Read More 3 Reasons Oncology Studies Should Consider a Pre-Configured eCOA Solution September 2, 2021 Signant Health Posted in eCOA The FDA’s recent guidance placed an increased emphasis on patient-reported outcome measures (PROMs) for oncology trials. This data provides better insight into the patients’ disease-related symptoms, side effects of treatment, and effect… Read More Direct-to-Patient Clinical Supply Distribution: Everything You Need to Know August 27, 2021 Signant Health Posted in Clinical Supplies The adoption of decentralized studies has rapidly increased thanks in part to the recent pandemic, which encouraged regulators to permit more flexibility within protocols and forced sponsors to implement… Read More Previous 1 2 3 4 Next
Author: Signant Health CTAD 2021: Scientific Posters Compilation November 17, 2021 Signant Health Posted in Scientific Advisory At the 14th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, hosted in Boston from November 9-12, 2021, Signant’s renowned… Read More Benefits of Integrating SmartSignals RTSM with Supplies Solutions November 2, 2021 Signant Health Posted in Clinical Supplies Have you been considering your upcoming study’s supply chain strategy? You’ll want digital tools that are designed for your specific trial. Look no… Read More 5 Reasons to Prioritize Rater Training October 29, 2021 Signant Health Posted in Scientific Advisory The quality of assessments is an essential clinical trial component that is often overlooked. In placebo-controlled trials, accurate ratings are… Read More Get to Know the SME: Todd Feaster, PsyD. October 11, 2021 Signant Health Posted in Scientific Advisory In the first of this new series of Q&A interviews with Signant’s subject matter experts, we sat down with Todd… Read More 2021 SCRS Global Site Solutions Summit Recap October 5, 2021 Signant Health Posted in Events This past week, Signant Health’s Chief Marketing Officer, Scott Connor, and Chief Operating Officer, Jason Martin, participated as panelists at… Read More ISCTM Autumn Conference 2021: Poster Presentations Roundup October 5, 2021 Signant Health Posted in Events The International Society for CNS Clinical Trials and Methods (ISCTM) hosted its 2021 Autumn Conference from Sept 30 – October… Read More eCOA Best Practices: Ensuring Timely Delivery of Translations October 4, 2021 Signant Health Posted in eCOA With more than half of all registered studies occurring in locations outside of the U.S. and the continued upward trajectory… Read More eConsent Task Force Co-Chaired by Signant and Medidata Honored as Finalists for TOPRA Innovation Award September 16, 2021 Signant Health Posted in eConsent In 2019, a team of industry experts formed a task force to examine challenges and opportunities in the adoption of… Read More 3 Reasons Oncology Studies Should Consider a Pre-Configured eCOA Solution September 2, 2021 Signant Health Posted in eCOA The FDA’s recent guidance placed an increased emphasis on patient-reported outcome measures (PROMs) for oncology trials. This data provides better insight into the patients’ disease-related symptoms, side effects of treatment, and effect… Read More Direct-to-Patient Clinical Supply Distribution: Everything You Need to Know August 27, 2021 Signant Health Posted in Clinical Supplies The adoption of decentralized studies has rapidly increased thanks in part to the recent pandemic, which encouraged regulators to permit more flexibility within protocols and forced sponsors to implement… Read More Previous 1 2 3 4 Next